til<3D
NZK du Hurensohn
- Joined
- Jan 12, 2026
- Posts
- 716
- Reputation
- 1,165
PHARMACEUTICAL MEGATHREAD
Skin, Vascularity, Fat Loss, Cognitive Enhancement & PEDs
April 2026
Skin, Vascularity, Fat Loss, Cognitive Enhancement & PEDs
April 2026
DISCLAIMER | |
Legal | These are pharmaceutical compounds requiring prescriptions in most countries. This guide is for educational purposes only. Not medical advice. |
Covered | Section I: Skin & Dermatology | Section: ||: Fat Loss and Metabolic Shredding | Section III: Vascularity & Performance | Section IV: Cognitive Enhancement (Nootropics) | Section V: Hormonal Modulation |
Section V | I honestly have very little knowledge about steroids in general, so I just included the input I happened to know. I’d definitely say there are much better threads out there on this topic. |
QUICK REFERENCE
Compound | Category | Evidence | Key Use | Cost | Overall |
Tretinoin | I | A+ | Vitamin A derivative (retinoid). | 9/10 | 10/10 |
Isotretinoin (Accutane) | I | A+ | Systemic oral retinoid... | 6/10 | 9/10 |
Azelaic Acid | I | A | Dicarboxylic acid with multiple mechanisms. | 9/10 | 8/10 |
Adapalene (0.1% / 0.3%) | I | A | Third generation retinoid. | 9/10 | 7/10 |
Finasteride | I | A | Type II 5 alpha reductase inhibitor. | 9/10 | 7/10 |
Dutasteride | I | B+ | Inhibits BOTH type I and type II 5 alpha reductase, reducing DHT by ~95% vs finasteride's ~70%. | 8/10 | 7/10 |
Ketoconazole (Topical) | I | B | Imidazole antifungal used topically as shampoo or cream. | 10/10 | 6/10 |
Clenbuterol | || | A | Powerful thermogenic for final contest prep / extreme cutting. | 9/10 | 7/10 |
Salbutamol (Albuterol) | || | A | Manageable fat loss & bronchodilation, short acting. | 10/10 | 6/10 |
Yohimbine HCL | || | B+ | Fasted cardio tool for alpha 2 receptor (stubborn fat) blockade. | 9/10 | 6/10 |
Liothyronine (T3) | || | A | Direct metabolic acceleration, high risk of muscle wasting. | 8/10 | 5/10 |
Levothyroxine (T4) | || | A | Long term metabolic baseline support, smoother than T3. | 9/10 | 6/10 |
Metformin | || | A+ | Insulin sensitivity & AMPK activation, "Health-Maxxing" during cut. | 10/10 | 9/10 |
DNP (2,4 Dinitrophenol) | || | B | Lethal mitochondrial uncoupling, extreme weight loss. | 5/10 | 0/10 |
Sibutramine | || | B- | Aggressive appetite suppression, high cardiovascular risk. | 6/10 | 3/10 |
Tirzepatide (Mounjaro) | || | A+ | The "God tier" GLP-1/GIP agonist for total appetite control. | 10/10 | 10/10 |
Orlistat | || | A | Blocking dietary fat absorption, for high fat "cheat" scenarios. | 8/10 | 4/10 |
Tadalafil (Cialis) | III | A | PDE5 inhibitor with ~17. | 8/10 | 8/10 |
Sildenafil (Viagra) | III | A | The original PDE5 inhibitor. | 8/10 | 7/10 |
Telmisartan | III | A | AT1 receptor antagonist (ARB) for hypertension. | 9/10 | 6/10 |
Nebivolol | III | A | Third generation selective beta 1 blocker. | 8/10 | 6/10 |
Modafinil | IV | A | Wakefulness promoting agent originally developed for narcolepsy. | 8/10 | 8/10 |
Armodafinil | IV | A | R-enantiomer of modafinil... | 7/10 | 8/10 |
Piracetam | IV | B | The original racetam, synthesized in 1964. | 9/10 | 6/10 |
Aniracetam | IV | B- | Fat soluble racetam with additional anxiolytic properties. | 8/10 | 5/10 |
Phenylpiracetam | IV | C+ | Piracetam with a phenyl group added produces stimulant effects in addition to cognitive enhancement. | 7/10 | 5/10 |
Pramiracetam | IV | B- | One of the most potent racetams per mg. | 6/10 | 5/10 |
Semax | IV | B+ | Synthetic ACTH(4-7) analogue developed in Russia for cognitive enhancement and neuroprotection. | 8/10 | 8/10 |
Memantine | IV | A | NMDA receptor antagonist approved for Alzheimer's treatment. | 7/10 | 5/10 |
Donepezil | IV | B+ | An atypical stimulant with anxiolytic properties (Actoprotector). Developed in Russia. | 6/10 | 9/10 |
Methylphenidate (Ritalin) | IV | A+ | Laser like focus. Immediate suppression of "distraction." | 9/10 | 9/10 |
Lisdexamfetamine (Vyvanse / Elvanse) | IV | A+ | 10-12 hours of ultra consistent focus. Less edgy than Ritalin. High functional output. | 5/10 | 8/10 |
Test Enanthate / Cypionate | V | A+ | The bio identical foundation of any hormonal cycle. Essential for nitrogen retention and muscle protein synthesis. | 10/10 | 10/10 |
Masteron (Drostanolone) | V | B | Providing a "hard," dry look: acts as a mild anti estrogen. Best used at low body fat. | 7/10 | 8/10 |
Anavar (Oxandrolone) | V | A | Significant strength gains and muscle fullness without water retention (dry gains). | 4/10 | 9/10 |
Winstrol (Stanozolol) | V | B+ | Achieving the "Granite Look", flushes out subcutaneous water. | 8/10 | 9/10 |
Enclomiphene | V | B+ | Raising natural testosterone levels while preserving fertility and testicular size. | 7/10 | 9/10 |
Anastrozole (Arimidex) | V | A | Managing high Estrogen (E2) side effects like bloating or early stage Gyno. | 6/10 | 10/10 |
Exemestane (Aromasin) | V | A | Irreversibly binds to the aromatase enzyme, prevents "Estrogen Rebound." | 6/10 | 9/10 |
Tamoxifen (Nolvadex) | V | A | Blocking Estrogen in breast tissue and restarting natural testosterone production (HPTA). | 10/10 | 10/10 |
Raloxifene | V | A | The most effective compound for reversing existing Gynaecomastia (glandular tissue). | 4/10 | 9/10 |
| V | A | Lowering Prolactin levels: treats "puffy nipples" and significantly reduces the sexual refractory period. | 2/10 | 8/10 |
COMPOUND PROFILES
── I. FACIAL AESTHETICS & SKIN ──
── I. FACIAL AESTHETICS & SKIN ──
TRETINOIN | |
Category | I. Facial Aesthetics & Skin |
Intro | Vitamin-A derivative (retinoid). The gold standard topical for acne treatment, skin texture improvement, and collagen stimulation. Requires prescription in most countries but widely available via online pharmacies. One of the most evidence backed topical compounds in dermatology. |
Mechanism | Binds RAR alpha, beta, gamma nuclear receptors → upregulates keratinocyte differentiation genes. Accelerates cell turnover (shortens skin cycle from 28 to 14 days). Inhibits comedogenesis. Stimulates collagen I/III synthesis via TGF beta pathway. |
Benefits | Acne clearance (inflammatory and non inflammatory). PIE/PIH reduction via cell turnover. Anti aging effects (reduces fine lines, improves texture). Collagen synthesis. Long term: skin rejuvenation. |
Negatives | Retinization period: peeling, redness, sensitivity weeks 1-8 (not a reason to stop). Photosensitization: SPF mandatory. Pregnancy category X, absolutely contraindicated. |
Dosage | 0.025% start → titrate to 0.05-0.1%. Pea sized amount entire face. |
Timing | Nights only. 20-30 min after cleansing on dry skin. Moisturizer after. |
Cycling | Continuous, no cycling. Effects compound over 6-12 months. |
Cost | €15-40 via online pharmacies. |
Evidence Grade | A+ Gold standard dermatology compound. Decades of RCT data. |
Synergies | Azelaic acid (PIE stack). Niacinamide (barrier support). GHK-Cu (complementary collagen). |
Warnings | SPF 50+ daily mandatory. Never use with benzoylperoxide same application. Buffer method (moisturizer first) reduces irritation. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
10/10 | 8/10 | 10/10 | 9/10 | 10/10 |
ISOTRETINOIN (ACCUTANE) | |
Category | I. Facial Aesthetics & Skin |
Intro | Systemic oral retinoid. The only pharmaceutical that permanently reduces sebaceous gland size and output essentially resets the skin. Used for moderate severe acne. The most effective acne treatment in existence. |
Mechanism | Systemic RAR activation → sebaceous gland atrophy (permanent reduction in sebum output by ~90%). Normalizes follicular keratinization. Anti inflammatory. Modulates immune cells in skin. |
Benefits | Permanent acne resolution in most patients. Skin texture transformation. Anti aging effects (deeper retinoid effects than topical). Long term remission rates >80% after one course. |
Negatives | Initial flare possible. Dry lips/skin/eyes (standard). Mood effects (monitor). Liver enzyme elevation |
Dosage | 0.5-1mg/kg/day. Typical course 16-24 weeks to cumulative 120-150mg/kg. |
Timing | With fatty meal (fat soluble). |
Cycling | Single course usually sufficient. Repeat if relapse. |
Cost | €50-200/month depending on dose and source. |
Evidence Grade | A+ Most effective acne treatment in existence. Decades of data. |
Synergies | Moisturizer + SPF (essential alongside). Lip balm. |
Warnings | Pregnancy Category X catastrophic birth defects. Mental health monitoring. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
10/10 | 7/10 | 10/10 | 6/10 | 9/10 |
AZELAIC ACID | |
Category | I. Facial Aesthetics & Skin |
Intro | Dicarboxylic acid with multiple mechanisms. Available OTC at 10% or prescription at 20%. Particularly effective for PIE, rosacea, and mild-moderate acne. UV stable can be used morning or evening. |
Mechanism | Inhibits tyrosinase (reduces melanin/PIE). Antibacterial against P. acnes (without resistance development). Anti inflammatory (inhibits IL-1, TNF-alpha, reactive oxygen species). Mild keratolytic. |
Benefits | PIE and redness reduction. Acne treatment (mild-moderate). Rosacea. Well tolerated, suitable for sensitive skin. UV stable means morning use fine. |
Negatives | Mild tingling/burning initially. 15-20% may experience skin irritation. Slower acting than tretinoin. |
Dosage | 10% OTC or 20% prescription. Thin layer affected areas. |
Timing | Morning (UV stable) or evening after tretinoin (wait 20 min). |
Cycling | Continuous. |
Cost | €10-25 for prescription 20% strength. |
Evidence Grade | A FDA approved for acne and rosacea. Extensive RCT data. |
Synergies | Tretinoin (dual PIE attack). Niacinamide. Tinted sunscreen. |
Warnings | Mild initial irritation normal. If persistent burning stop use. Do not combine with high concentration glycolic acid. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
8/10 | 9/10 | 9/10 | 9/10 | 8/10 |
ADAPALENE (0.1% / 0.3%) | |
Category | I. Facial Aesthetics & Skin |
Intro | Third generation retinoid. Binds RAR-beta and gamma but NOT alpha, the receptor responsible for most retinoid side effects. This selectivity makes it significantly less irritating than tretinoin while maintaining comparable efficacy for acne. |
Mechanism | RAR-beta/gamma selectivity → keratinocyte differentiation without RARa-mediated irritation. Inhibits AP-1 transcription factor → anti-inflammatory. TLR-2 modulation → immune response in follicles. |
Benefits | Acne efficacy comparable to tretinoin 0.025%. Significantly less irritation. Available OTC (0.1% in some countries). Better option for sensitive skin or during tretinoin retinization. |
Negatives | Weaker than tretinoin 0.05-0.1% for anti aging and texture. Less collagen stimulation than tretinoin. Still causes some photosensitization. |
Dosage | Pea sized 0.1% nightly. Can step up to 0.3%. |
Timing | Night only. After cleansing. |
Cycling | Continuous. |
Cost | €15-30 OTC. |
Evidence Grade | A FDA approved. RCT data comparable to tretinoin for acne. |
Synergies | Azelaic acid. Niacinamide. |
Warnings | SPF mandatory. Not as powerful as tretinoin for skin remodeling — use tretinoin if tolerated. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
7/10 | 9/10 | 9/10 | 9/10 | 7/10 |
FINASTERIDE | |
Category | I. Facial Aesthetics & Skin |
Intro | Type II 5-alpha reductase inhibitor. Reduces DHT by ~70%. Used clinically for BPH and male pattern baldness. The most common pharmaceutical intervention for hair loss. At 17-18 years use with extreme caution given ongoing hormonal development. |
Mechanism | Inhibits 5-alpha reductase type II → reduces conversion of testosterone to DHT in hair follicles and prostate. DHT binds AR on dermal papilla cells → miniaturization. Finasteride prevents this. |
Benefits | Halts and partially reverses androgenetic alopecia. Reduces DHT systemically. Skin quality improvement in acne-prone users. |
Negatives | Post finasteride syndrome (persistent sexual dysfunction in subset of users, mechanism debated). Reduces DHT ~70% systemically affecting all DHT-dependent processes. Libido changes. Not for use under 18. |
Dosage | 1mg/day for hair loss. |
Timing | Any time, consistent. |
Cycling | Continuous stopping causes DHT rebound and renewed hair loss. |
Cost | €15-30/month generic. |
Evidence Grade | A FDA approved. Decades of RCT data for AGA. |
Synergies | Minoxidil topical (gold standard hair loss stack). |
Warnings | Not recommended at 17-18 due to ongoing hormonal development. Post-finasteride syndrome, small but real risk. Monitor libido/sexual function. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
8/10 | 8/10 | 9/10 | 9/10 | 7/10 |
DUTASTERIDE | |
Category | I. Facial Aesthetics & Skin |
Intro | Inhibits BOTH type I and type II 5-alpha reductase —> reducing DHT by ~95% vs finasteride's ~70%. More potent hair loss treatment but also more systemic DHT suppression. Used off label for hair loss. |
Mechanism | Dual type I/II 5AR inhibition → ~95% DHT reduction. Type I found in skin and liver (unlike finasteride which only hits type II). More complete DHT suppression. |
Benefits | Superior hair retention vs finasteride in head-to-head studies. Greater scalp DHT reduction. Skin acne improvement. |
Negatives | All finasteride warnings apply, amplified. 95% DHT reduction is significant, DHT has important roles in libido, cognitive function, muscle fullness. Not for under 18. |
Dosage | 0.5mg every day or 2.5mg weekly. |
Timing | Any time. |
Cycling | Continuous. |
Cost | €20-40/month. |
Evidence Grade | B+ Multiple RCTs vs finasteride and placebo. Not FDA approved for hair loss (approved for BPH). |
Synergies | Minoxidil topical. |
Warnings | Even stronger systemic DHT suppression than finasteride. Same post-finasteride syndrome risk. Not at 17-18. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
8/10 | 7/10 | 8/10 | 8/10 | 7/10 |
KETOCONAZOLE (TOPICAL) | |
Category | I. Facial Aesthetics & Skin |
Intro | Imidazole antifungal used topically as shampoo or cream. Directly inhibits DHT binding at androgen receptors in scalp follicles. Widely available OTC as shampoo (Nizoral). Often used as adjunct in hair loss protocols. |
Mechanism | Inhibits sterol synthesis in fungi (antifungal mechanism). In hair follicles: directly competes with DHT at androgen receptor. Also reduces scalp inflammation. Some sebum reduction. |
Benefits | Adjunct hair loss treatment. Seborrheic dermatitis treatment. Anti-inflammatory scalp effects. Minimal systemic absorption from topical use. |
Negatives | Only topical, very limited systemic effects. May dry hair with frequent use. Not a standalone hair loss treatment. |
Dosage | Nizoral shampoo 2%, leave 5 min on scalp 2-3x/week. |
Timing | Any time during shower. |
Cycling | Continuous. |
Cost | €8-15/month. |
Evidence Grade | B Controlled studies showing hair loss benefit as adjunct. Less RCT data than finasteride. |
Synergies | Finasteride or dutasteride (complementary mechanism, receptor blockade vs DHT reduction). |
Warnings | Minimal safety concerns with topical use. Some users report hair dryness. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
6/10 | 10/10 | 6/10 | 10/10 | 6/10 |
── II. Fat Loss and Metabolic Shredding ──
CLENBUTEROL | |
Category | II. Fat Loss and Metabolic Shredding |
Intro | A potent Beta-2 adrenoceptor agonist. While technically a bronchodilator for asthma, it is the bodybuilding gold standard for non hormonal fat loss and final contest prep. |
Mechanism | Stimulates Beta-2 receptors → increases cAMP levels → elevates core body temperature (thermogenesis) → increases Basal Metabolic Rate (BMR) by ~5-10%. |
Benefits | Rapid fat oxidation. Slight anti catabolic effect (muscle sparing) during heavy deficits. Direct stimulation of the central nervous system for increased output. |
Negatives | Long half life (~36h) means side effects persist 24/7. Jitters (tremor), insomnia, heavy sweating, and significant cardiac stress (tachycardia). Depletes intracellular Taurine levels. |
Dosage | 20mcg start → titrate up by 20mcg every few days up to 80-120mcg (advanced only). |
Timing | Morning (due to long HWZ). |
Cycling | Strictly 2 weeks on / 2 weeks off (to prevent receptor downregulation) or used with Ketotifen. |
Cost | €15-30 per bottle / pack. |
Evidence Grade | A (Extensive use in sports pharmacology). |
Synergies | Taurine (3-5g daily) to prevent muscle cramps. T3 (often stacked in pro protocols, but high muscle loss risk). |
Warnings | Potentially kardiotoxisch at high doses or long term use. Monitor heart rate and blood pressure constantly. Absolute contraindication with existing heart conditions. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
9/10 | 5/10 | 9/10 | 9/10 | 7/10 |
SALBUTAMOL (ALBUTEROL) | |
Category | II. Fat Loss and Metabolic Shredding |
Intro | A short-acting Beta-2 adrenoceptor agonist. Primarily used as a bronchodilator for asthma, but highly effective for metabolic enhancement and fat loss in a fitness context.. |
Mechanism | Stimulates Beta-2 receptors → increases cAMP levels → triggers lipolysis in adipose tissue and a slight thermogenic effect. It has a much shorter half life (~4-6 hours) compared to Clenbuterol, allowing for precise control. |
Benefits | Boosts metabolic rate (I would say 200 extra kcal/day). Improved breathing/cardio performance via bronchodilation. Significantly less CNS strain than long-acting stimulants. |
Negatives | Can cause temporary jitters, increased heart rate (tachycardia), and mild blood pressure fluctuations. Potential for muscle cramps due to electrolyte shifts. |
Dosage | 4mg per dose, typically 1-3 times daily. Start with 4mg once in the morning to assess tolerance. |
Timing | Morning (due to HWZ). |
Cycling | Effective for short term use (e.g., the last 4 weeks of a cut). Receptor downregulation occurs with prolonged use. |
Cost | €10-25 via pharmacy or online. Often very accessible. |
Evidence Grade | A (Extensive clinical and athletic data). |
Synergies | Taurine (3-5g daily) to prevent muscle cramps. |
Warnings | Monitor heart rate and blood pressure (RR). Stop immediately if arrhythmias occur. Caution when stacking with other stimulants or if baseline RR is already low. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
8/10 | 8/10 | 10/10 | 10/10 | 8/10 |
YOHIMBINE HCL | |
Category | II. Fat Loss and Metabolic Shredding |
Intro | An alpha-2 adrenoceptor antagonist derived from the bark of the African Yohimbe tree. It is specifically used for targeting "stubborn" fat areas that are resistant to normal dieting. |
Mechanism | Blocks alpha-2 adrenoreceptors in adipose tissue. These receptors normally inhibit lipolysis (fat breakdown); by blocking them, Yohimbine allows catecholamines to bind to beta receptors and mobilize fat from "problem areas" like the lower back and glutes. |
Benefits | Targeted lipolysis in areas with high alpha-2 density. Increased vascularity and blood flow. Works as a mild stimulant. |
Negatives | Can trigger significant anxiety, cold sweats, and "inner unrest." Increases heart rate and potentially blood pressure. Insulin completely blunts the effect, making timing critical. |
Dosage | 0.2mg per kg of bodyweight (e.g., ~18mg for a 90kg individual). Start lower to assess tolerance. |
Timing | Must be taken in a fasted state (ideally pre cardio). Even a small insulin spike from food renders it useless for fat loss. |
Cycling | Effective as needed; no specific downward regulation, but ZNS fatigue can occur. |
Cost | €15-30 via specialized supplement sites or pharmacies. |
Evidence Grade | B+ (Solid mechanistic data and several human trials for fat loss). |
Synergies | Caffeine (amplifies the effect). Fasted LISS cardio. |
Warnings | Do not use if prone to anxiety or panic attacks. Avoid stacking with heavy stimulants if your baseline heart rate is already high. Monitor RR carefully. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
7/10 | 4/10 | 8/10 | 9/10 | 6/10 |
LIOTHYRONINE (T3) | |
Category | II. Fat Loss and Metabolic Shredding |
Intro | Synthetic form of the thyroid hormone triiodothyronine (T3). It is the most metabolically active thyroid hormone and a powerful tool for accelerating fat loss by directly increasing the body's basal metabolic rate. |
Mechanism | Directly binds to thyroid hormone receptors in cell nuclei → increases mitochondrial activity and ATP turnover → accelerates the metabolism of carbohydrates, proteins, and fats. |
Benefits | Massive increase in caloric expenditure even at rest. Highly effective for breaking through fat loss plateaus |
Negatives | Extremely catabolic: without adequate anabolic protection (AAS), it will rapidly burn muscle tissue alongside fat. Can cause heart palpitations, anxiety, heat intolerance, and permanent thyroid suppression if abused. |
Dosage | 12.5mcg - 25mcg daily for beginners. Experienced users may go up to 50mcg. Titration is mandatory. |
Timing | In the morning on an empty stomach, ideally 30–60 minutes before your first meal. |
Cycling | Usually limited to 4-8 weeks to minimize the risk of long term thyroid downregulation. |
Cost | €15-40 via pharmacy or online sources. |
Evidence Grade | A (Extensively studied in clinical and sports settings). |
Synergies | Anabolic steroids (to prevent muscle wasting). Clenbuterol/Salbutamol (often stacked for synergistic thermogenesis, but adds massive cardiac strain). |
Warnings | Monitor resting heart rate and body temperature. If resting HR exceeds 100 bpm, reduce dosage immediately. Risk of permanent hypothyroidism with improper use. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
10/10 | 4/10 | 10/10 | 5/10 | 5/10 |
LEVOTHYROXINE (T4) | |
Category | II. Fat Loss and Metabolic Shredding |
Intro | The synthetic precursor to the active thyroid hormone T3. It is the standard treatment for hypothyroidism but is used in performance contexts to maintain a high normal metabolic baseline during extended cutting phases. |
Mechanism | Acts as a pro hormone that is converted into active T3 by deiodinase enzymes in the liver and peripheral tissues. This allows the body to regulate the conversion rate based on physiological demand, leading to more stable blood levels. |
Benefits | Provides a smoother, more predictable metabolic boost compared to T3. Lower risk of acute muscle wasting (catabolism). Helps prevent the metabolic slowdown associated with chronic caloric restriction (e.g. when using Tirzepatide). |
Negatives | Slower onset of action due to the required conversion process. Can still lead to hyperthyroid symptoms (insomnia, palpitations) if dosed too high. Requires several weeks to reach a steady state. |
Dosage | 50mcg - 100mcg daily. Individual requirements vary significantly; blood work for TSH and fT4 is recommended. |
Timing | In the morning on an empty stomach, ideally 30–60 minutes before your first meal. |
Cycling | Often used for longer durations (8-12 weeks) during a cut. Should be tapered off gradually to allow natural thyroid function to recover. |
Cost | €10-25 via pharmacy. Very cost-effective. |
Evidence Grade | A+ (Gold standard for thyroid replacement therapy with immense clinical data). |
Synergies | Human Growth Hormone (HGH), as HGH can accelerate the conversion of T4 to T3. GH Secretagogues. |
Warnings | Less "feelable" than T3, which often leads to dangerous over dosing. Monitor heart rate and temperature. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
6/10 | 7/10 | 10/10 | 10/10 | 6/10 |
METFORMIN | |
Category | II. Fat Loss and Metabolic Shredding |
Intro | A biguanide primarily used for Type-2 Diabetes management, but highly popular in the longevity and bodybuilding communities for its metabolic and anti-aging properties. |
Mechanism | Activates AMPK (adenosine monophosphate activated protein kinase) → mimics the physiological effects of fasting. It inhibits hepatic glucose production and increases insulin sensitivity in peripheral tissues. |
Benefits | Prevents fat storage by improving nutrient partitioning. Lowers systemic inflammation and reduces IGF-1/mTOR signaling (longevity benefit). Helps maintain a lean physique. |
Negatives | Gastrointestinal issues (diarrhea, bloating) are common during the titration phase. May slightly reduce maximal hypertrophy due to mTOR inhibition. Potential for Vitamin B12 deficiency over long term use. |
Dosage | 500mg - 1000mg daily. Start with 500mg to assess GI tolerance. |
Timing | With or immediately after a meal (usually in the evening) to minimize gastrointestinal discomfort. |
Cycling | Often used continuously. Some athletes cycle it "off" during heavy mass building phases to maximize mTOR signaling. |
Cost | €10-20 per pack. Extremely cost effective and widely available. |
Evidence Grade | A+ (One of the most researched drugs in existence with decades of safety data). |
Synergies | Berberine (natural alternative/add on). Tirzepatide (excellent synergy for glucose control and weight loss). |
Warnings | Risk of lactic acidosis (extremely rare in healthy individuals). Monitor B12 levels. Avoid excessive alcohol consumption while on Metformin. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
7/10 | 8/10 | 10/10 | 10/10 | 9/10 |
DNP (2,4-DINITROPHENOL) | |
Category | II. Fat Loss and Metabolic Shredding |
Intro | An industrial chemical used in the manufacturing of explosives and dyes. It was briefly used as a weight loss drug in the 1930s before being banned due to extreme toxicity and fatalities. |
Mechanism | Acts as a mitochondrial uncoupler. It dissipates the proton gradient across the inner mitochondrial membrane, forcing the body to burn energy (fat and carbs) as pure heat instead of producing ATP. |
Benefits | Unmatched fat loss (up to 0.5kg of pure fat per day). No "ceiling" to its effectiveness. |
Negatives | Fatal Hyperthermia: The body literally cooks from the inside out; there is no physiological cooling mechanism that can counteract DN induced heat. No Antidote: If you overdose, medical science cannot save you.Severe peripheral neuropathy, rapid onset cataracts (blindness), and multi organ failure. |
Dosage | Any dosage carries a risk of death. There is no "safe" therapeutic index. |
Timing | Irrelevant: the compound accumulates in the system due to a long half life, leading to accidental overdoses. |
Cycling | Should not be used. |
Cost | Low (Industrial chemical), but the "cost" is potentially your life. |
Evidence Grade | B (Documented as a potent fat burner, but primarily evidenced through toxicology reports and mortality cases). |
Synergies | None. Stacking with other stimulants or thyroid hormones significantly increases the risk of immediate death. |
Warnings | EXTREME LEFAL DANGER. Unlike Clenbuterol or T3, DNP does not have a biological "off switch." Inclusion in this guide is for historical and harm reduction purposes only. DO NOT USE. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
10/10 | 1/10 | 5/10 | 10/10 | 0/10 |
SIBUTRAMINE | |
Category | II. Fat Loss and Metabolic Shredding |
Intro | A serotonin norepinephrine reuptake inhibitor (SNRI) originally developed as an antidepressant but primarily used as a potent appetite suppressant. It was withdrawn from many markets due to cardiovascular safety concerns. |
Mechanism | Inhibits the reuptake of dopamine, norepinephrine, and serotonin in the brain → increases satiety and elevates resting metabolic rate via thermogenesis. |
Benefits | Aggressive suppression of "food noise" and appetite. Increased energy expenditure. Effective for rapid weight loss in the short term. |
Negatives | Significant cardiovascular strain: increases blood pressure and heart rate. High risk of dry mouth, insomnia, constipation, and in severe cases, stroke or myocardial infarction. |
Dosage | 10mg - 15mg daily. |
Timing | In the morning. |
Cycling | Not recommended for long term use (max. 4-12 weeks) due to cardiac stress. |
Cost | €20-40 via gray market sources: legally unavailable in most Western countries. |
Evidence Grade | B- (Documented efficacy for weight loss, but heavily overshadowed by safety data leading to its withdrawal). |
Synergies | None recommended. Stacking with other stimulants (like Salbutamol) exponentially increases the risk of a cardiac event. |
Warnings | High Cardiovascular Risk. Do not use if you have any history of hypertension or heart disease. Largely replaced by superior and safer GLP-1 agonists like Tirzepatide. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
8/10 | 7/10 | 6/10 | 6/10 | 3/10 |
TIRZEPATIDE (MOUNJARO) | Mogs Reta in my opinion |
Category | II. Fat Loss and Metabolic Shredding |
Intro | A dual glucose dependent insulinotropic polypeptide (GIP) and glucagon like peptide 1 (GLP-1) receptor agonist. Currently the most potent pharmaceutical tool for weight loss, surpassing Semaglutide (Ozempic) in both speed and total fat reduction. |
Mechanism | Acts on two key metabolic pathways: GLP-1 (delays gastric emptying, signals satiety to the brain) and GIP (improves insulin sensitivity and lipid metabolism). It effectively "mutes" the brain's hunger signals (Food Noise) while optimizing how the body handles glucose. |
Benefits | Extreme appetite suppression. Rapid fat loss while maintaining stable blood sugar. Improved insulin sensitivity. Minimal CNS stimulation compared to traditional burners (Clen/T3). |
Negatives | Gastrointestinal side effects (nausea, constipation, sulfur burps) especially during titration. High cost and availability issues. Potential for "muscle wasting" if protein intake isn't strictly monitored (due to massive caloric deficit). |
Dosage | 2.5mg start (4 weeks) → titrate to 5mg → 7.5mg → max 15mg weekly. |
Timing | Subcutaneous injection, once weekly (any time of day). |
Cycling | Can be used for the duration of a cut (8-16 weeks) or as a long term weight management tool. |
Cost | $170 for 600mg (depending on source/pharmacy). |
Evidence Grade | A+ (SURMOUNT clinical trials show up to 20%+ body weight loss). |
Synergies | High protein diet (mandatory). Metformin (for peak insulin sensitivity). Testosterone/AAS (to protect muscle mass during the deficit). |
Warnings | Risk of pancreatitis (rare). Must monitor gallbladder health. Do not use if you have a family history of medullary thyroid carcinoma (MTC). |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
10/10 | 9/10 | 10/10 | 10/10 | 10/10 |
Why it's NOT in the main Guide (yet):
- Cardiac Strain: Glucagon receptor activation increases resting heart rate significantly.
- Muscle Wasting: The metabolic drive is so high that maintaining a good looking body becomes nearly impossible without high dose anabolics.
- Experimental Status: No long term human safety data outside of clinical trials.
- Conclusion: Stick to Tirzepatide for controlled, elite level fat loss. Retatrutide is for those who are willing to be "human lab rats."
ORLISTAT | |
Category | II. Fat Loss and Metabolic Shredding |
Intro | A gastrointestinal lipase inhibitor. Unlike most other fat burners, it does not act on the central nervous system or metabolism directly; it works solely in the digestive tract to prevent the absorption of dietary fats. |
Mechanism | Inhibits the enzyme gastric and pancreatic lipase. These enzymes are necessary to break down triglycerides into free fatty acids. Without them, about 25-30% of ingested fat passes through the intestines undigested. |
Benefits | Non systemic (does not affect heart rate or blood pressure). Proven to reduce visceral fat over time. Can be used as a "cheat meal insurance" to limit caloric impact from high fat social events. |
Negatives | Gastrointestinal Side Effects: Frequent, oily spotting, flatulence with discharge ("sharting"), and urgent bowel movements. Malabsorption of fat soluble vitamins (A, D, E, K) and Beta Carotene. |
Dosage | 60mg (OTC/Alli) to 120mg (Prescription/Xenical) taken with each fat containing meal. |
Timing | Immediately before, during, or up to one hour after a high fat meal. |
Cycling | Can be used long term, but requires a hig quality multivitamin (taken 2 hours apart) to prevent deficiencies. |
Cost | €30-60 per month via pharmacy. |
Evidence Grade | A (Decades of clinical use and FDA approval). |
Synergies | Fiber supplements (Psyllium Husk) to mitigate GI side effects. |
Warnings | If a meal contains no fat, the dose should be skipped. Excessive fat intake while on Orlistat leads to severe "emergency" bathroom situations. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
4/10 | 2/10 | 10/10 | 7/10 | 3/10 |
── III. VASCULARITY & PERFORMANCE ──
TADALAFIL (CIALIS) | |
Category | III. Vascularity & Performance |
Intro | PDE5 inhibitor with ~17.5 hour half life the longest of the PDE5 inhibitors. Daily low dose creates true steady state NO enhancement. The most practical PDE5 inhibitor for ongoing vascularity and cardiovascular benefits. |
Mechanism | Inhibits phosphodiesterase type 5 → prevents cGMP breakdown → elevated cGMP → smooth muscle relaxation → vasodilation via NO pathway. Steady-state at 5mg EOD or 2.5-5mg daily. |
Benefits | Enhanced muscle pump and vascularity in training. Cardiovascular health (NO mediated endothelial protection). Blood pressure reduction. Erectile function. Potential cognitive benefits via cerebral blood flow. |
Negatives | Hypotension at low blood pressure baseline. Absolute contraindication with nitrates. Facial flushing, nasal congestion at high doses. Back pain (unique to tadalafil, PDE11 inhibition). |
Dosage | 2.5-5mg daily OR 5mg EOD for steady-state. 10-20mg as needed. |
Timing | Morning with or without food. |
Cycling | No cycling needed. Can be used continuously. |
Cost | €15-30/month generic. |
Evidence Grade | A FDA approved. Extensive RCT data for multiple indications. |
Synergies | L-Citrulline (complementary NO pathway, do not stack at high citrulline doses). Training. |
Warnings | Absolute contraindication with nitrates (life threatening hypotension). Avoid with alpha blockers. Monitor blood pressure, particularly at baseline <110/70. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
8/10 | 9/10 | 9/10 | 8/10 | 8/10 |
SILDENAFIL (VIAGRA) | |
Category | III. Vascularity & Performance |
Intro | The original PDE5 inhibitor. Shorter half-life (~4 hours) vs tadalafil, creates strong acute peak rather than steady state. More intense pump effect but not suitable for daily dosing. First choice for acute pre-workout vascularity. |
Mechanism | Same PDE5 inhibition as tadalafil but with faster onset (30-60 min) and shorter duration. Stronger acute NO amplification. More PDE5-selective than tadalafil (less PDE11 side effects). |
Benefits | Intense acute muscle pump pre-workout. Rapid onset. Strong vasodilation. No back pain (unlike tadalafil). |
Negatives | Short duration means less practical for daily use. Facial flushing, visual disturbances (blue tint) at high doses. Same contraindications as tadalafil. |
Dosage | 25-50mg 30-60 min pre workout. |
Timing | 30-60 min pre workout on empty stomach for fastest effect. |
Cycling | As needed only, not suitable for daily steady-state. |
Cost | €10-25 for several doses generic. |
Evidence Grade | A FDA approved. Extensive RCT data. |
Synergies | Training. Citrulline (reduce citrulline dose when stacking). |
Warnings | Same contraindications as tadalafil. Food significantly reduces absorption. Vision disturbances (blue tint) possible. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
8/10 | 8/10 | 9/10 | 8/10 | 7/10 |
TELMISARTAN | |
Category | III. Vascularity & Performance |
Intro | AT1 receptor antagonist (ARB) for hypertension. Unique additional mechanism, PPAR-gamma partial agonist → metabolic benefits beyond blood pressure. Used in performance context for cardiovascular protection and endurance enhancement. |
Mechanism | Blocks angiotensin II AT1 receptor → vasodilation, reduced aldosterone, lower blood pressure. PPAR-gamma activation → improved insulin sensitivity, fatty acid oxidation, mitochondrial biogenesis. Crosses BBB — potential nootropic effects. |
Benefits | Blood pressure control in steroid users. Endurance enhancement via PPAR-gamma (AICAR like metabolic effects). Cardiovascular protection. Potential insulin sensitivity improvement. |
Negatives | Hypotension at low blood pressure baseline, ot indicated in normal or low BP individuals without specific reason. Hyperkalemia risk. |
Dosage | 20-40mg/day for cardioprotection. 80mg/day for hypertension. |
Timing | Morning. |
Cycling | Continuous for hypertension management. |
Cost | €10-20/month generic. |
Evidence Grade | A FDA approved. PPAR-gamma mechanism adds unique performance angle. |
Synergies | Cardiovascular protection stack. PPAR gamma effects synergy with cardio training. |
Warnings | Not appropriate if blood pressure already low (baseline <120/75). Monitor potassium. Not a performance supplement for healthy normotensive individuals. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
7/10 | 7/10 | 8/10 | 9/10 | 6/10 |
NEBIVOLOL | |
Category | III. Vascularity & Performance |
Intro | Third generation selective beta 1 blocker. Unique among beta-blockers, stimulates eNOS → increases NO production. Provides cardiovascular protection without the exercise performance reduction seen with older beta-blockers. |
Mechanism | Beta-1 selective blockade → reduced heart rate and cardiac workload. Unique: stimulates endothelial NO synthase (eNOS) → vasodilation. Unlike older beta-blockers, does not significantly impair exercise capacity due to NO effects. |
Benefits | Cardiovascular protection when using stimulants (Modafinil, Salbutamol). Blood pressure reduction without exercise impairment. Vasodilation via NO. Anxiety reduction in performance situations. |
Negatives | Still some reduction in maximum heart rate. Not for asthma/COPD (beta blockade). Bradycardia at excessive doses. |
Dosage | 2.5-5mg/day. |
Timing | Morning. |
Cycling | Continuous when indicated. |
Cost | €15-25/month. |
Evidence Grade | A FDA approved for hypertension. eNOS mechanism well characterized. |
Synergies | Stimulant stack cardiac protection. Talmisartan. |
Warnings | Not for asthma. Monitor resting heart rate. Only use when cardiovascular protection specifically needed. |
Ratings:
Effectiveness | Ease | Evidence | Cost | Overall |
6/10 | 7/10 | 8/10 | 8/10 | 6/10 |
@tqbiq @Jesus_ist_König @Datto29 @OCD @Niebvll
DNP (2,4 Dinitrophenol)